RNA‐binding motif protein 6 (RBM6), as a member of the RBM family, has been reported to be associated with a variety of tumours, for example, RBM6 inhibits laryngocarcinoma but promotes lung cancer [13, 14], however its relationship with prostate tumours has been unclear. Here, RBM6 is linked to neoplasm.